Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Amplitude Surgical SAS
AMPLIAmplitude Surgical SA develops and markets products for orthopedic surgery. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. In addition, the company provides instruments for fitting related accessories. It sells its products through a network of distributors and agents in approximately 30 countries. The company serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. As of January 21, 2021, Amplitude Surgical SA operates as a subsidiary of PAI Partners. Address: 11, Cours Jacques Offenbach, Valence, France, 26000
Analytics
Zielpreis von Wall Street
4.04 EURKGV
104.6667Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen AMPLI
Dividenden-Analyse AMPLI
Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
–Verlauf der Dividende AMPLI
Bewertung der Aktie AMPLI
Finanzen AMPLI
Ergebnisse | 2019 | Dynamik |